Delivery Order SPE2DB20D3101-SPE2DB23FRMM9
Award Date 5/25/23
Potential Completion Date 5/26/23
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,211.88, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,450,464 units of Naloxone HCL 4 mg Nasal Spray, with an ultimate completion date of November 18, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,367,200 units of Naloxone HCL 4 mg Nasal Spray. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,950.71 and an ultimate completion date of August 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award is for the delivery of 4,559,406,389 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The award, valued at $3,854.16, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 19, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of 4,565,116,322 units of Naloxone HCl 4 mg Nasal Spray. The $2,630.37 firm-fixed-price delivery order does not have a set-aside designation, indicating open competition. The award is associated with a larger $999,999,999 Indefinite Delivery Contract held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,252,687 units of Naloxone HCL 4 mg nasal spray. The contract has a Firm Fixed Price (FFP) pricing type, a ceiling value of $46,516.61, and an ultimate completion date of September 21, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award, valued at $1,405.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the procurement of 4,567,316,980 units of 4 mg naloxone HCl nasal spray. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- This federal contract award, valued at $1,838.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,999,320 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. This delivery order contract has a firm fixed-price pricing type and an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp also...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,632,850 units of NALOXONE HCL 4 MG NASAL SPRAY 2S. The fixed-price delivery order, valued at $1,217.04, has a period of performance through March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award is for the delivery of 4,563,299,256 units of Naloxone HCL 4 mg Nasal Spray. The $9,713.59 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 11, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,983,291 units of Naloxone HCL 4 mg Nasal Spray. The delivery order, valued at $1,845.84, has a firm fixed-price and is expected to be completed by May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...